Literature DB >> 8144028

The human glucagon receptor encoding gene: structure, cDNA sequence and chromosomal localization.

S Lok1, J L Kuijper, L J Jelinek, J M Kramer, T E Whitmore, C A Sprecher, S Mathewes, F J Grant, S H Biggs, G B Rosenberg.   

Abstract

Characterization of the human glucagon-receptor-encoding gene (GGR) should provide a greater understanding of blood glucose regulation and may reveal a genetic basis for the pathogenesis of diabetes. A cDNA encoding a complete functional human glucagon receptor (GGR) was isolated from a liver cDNA library by a combination of polymerase chain reaction and colony hybridization. The cDNA encodes a receptor protein with 80% identity to rat GGR that binds [125I]glucagon and transduces a signal leading to increases in the concentration of intracellular cyclic adenosine 3',5'-monophosphate. Southern blot analysis of human DNA reveals a hybridization pattern consistent with a single GGR locus. In situ hybridization to metaphase chromosome preparations maps the GGR locus to chromosome 17q25. Analysis of the genomic sequence shows that the coding region spans over 5.5 kb and is interrupted by 12 introns.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8144028     DOI: 10.1016/0378-1119(94)90545-2

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  21 in total

Review 1.  Defining the genetic contribution of type 2 diabetes mellitus.

Authors:  J van Tilburg; T W van Haeften; P Pearson; C Wijmenga
Journal:  J Med Genet       Date:  2001-09       Impact factor: 6.318

Review 2.  Current insights and new perspectives on the roles of hyperglucagonemia in non-insulin-dependent type 2 diabetes.

Authors:  Xiao C Li; Jia L Zhuo
Journal:  Curr Hypertens Rep       Date:  2013-10       Impact factor: 5.369

Review 3.  Insulin and glucagon signaling in the central nervous system.

Authors:  Beatrice M Filippi; Mona A Abraham; Jessica T Y Yue; Tony K T Lam
Journal:  Rev Endocr Metab Disord       Date:  2013-12       Impact factor: 6.514

4.  The Use of Surfactants to Solubilise a Glucagon Analogue.

Authors:  Jens Kvist Madsen; Lise Giehm; Daniel E Otzen
Journal:  Pharm Res       Date:  2018-10-15       Impact factor: 4.200

5.  Acetylation negatively regulates glycogen phosphorylase by recruiting protein phosphatase 1.

Authors:  Tengfei Zhang; Shiwen Wang; Yan Lin; Wei Xu; Dan Ye; Yue Xiong; Shimin Zhao; Kun-Liang Guan
Journal:  Cell Metab       Date:  2012-01-04       Impact factor: 27.287

6.  Different domains of the glucagon and glucagon-like peptide-1 receptors provide the critical determinants of ligand selectivity.

Authors:  S Runge; B S Wulff; K Madsen; H Bräuner-Osborne; L B Knudsen
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

7.  Pancreatic beta-cell overexpression of the glucagon receptor gene results in enhanced beta-cell function and mass.

Authors:  Richard W Gelling; Patricia M Vuguin; Xiu Quan Du; Lingguang Cui; John Rømer; Raymond A Pederson; Margarita Leiser; Heidi Sørensen; Jens J Holst; Christian Fledelius; Peter B Johansen; Norman Fleischer; Christopher H S McIntosh; Erica Nishimura; Maureen J Charron
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-07-14       Impact factor: 4.310

8.  Hypothalamic glucagon signaling inhibits hepatic glucose production.

Authors:  Patricia I Mighiu; Jessica T Y Yue; Beatrice M Filippi; Mona A Abraham; Madhu Chari; Carol K L Lam; Clair S Yang; Nikita R Christian; Maureen J Charron; Tony K T Lam
Journal:  Nat Med       Date:  2013-05-19       Impact factor: 53.440

9.  Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice.

Authors:  R W Gelling; X Q Du; D S Dichmann; J Romer; H Huang; L Cui; S Obici; B Tang; J J Holst; C Fledelius; P B Johansen; L Rossetti; L A Jelicks; P Serup; E Nishimura; M J Charron
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-24       Impact factor: 11.205

Review 10.  Targeting glucagon receptor signalling in treating metabolic syndrome and renal injury in Type 2 diabetes: theory versus promise.

Authors:  Xiao C Li; Jia L Zhuo
Journal:  Clin Sci (Lond)       Date:  2007-08       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.